Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Acute Trauma Stress Response
NCT02753166Phase 1Withdrawn
- Sponsor
- NYU Langone Health
- Start
- Jan 2017
- Primary completion
- Dec 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dexamethasone in post-traumatic stress disorder (PTSD) (2 arms), sponsored by NYU Langone Health. Primary endpoint: PTSD Check-List 5 at 12 months. Planned start Jan 2017; status: withdrawn.
02
Drugs
dexamethasone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02753166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02753166.